22nd Century Inc logo

XXII - 22nd Century Inc Share Price

$0.982 -0.0  -0.1%

Last Trade - 3:26pm

Sector
Industrials
Size
Small Cap
Market Cap £94.1m
Enterprise Value £61.7m
Revenue £19.6m
Position in Universe 4092nd / 6412
Bullish
Bearish
Unlock XXII Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

XXII Revenue Unlock XXII Revenue

Net Income

XXII Net Income Unlock XXII Revenue

Normalised EPS

XXII Normalised EPS Unlock XXII Revenue

PE Ratio Range

XXII PE Ratio Range Unlock XXII Revenue

Dividend Yield Range

XXII Dividend Yield Range Unlock XXII Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
XXII EPS Forecasts Unlock XXII Revenue
Profile Summary

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated September 12, 2005
Public Since May 27, 2008
No. of Shareholders: 95
No. of Employees: 82
Sector Industrials
Industry Professional & Commercial Services
Index
Exchange NYSE MKT
Shares in Issue 125,772,581
Free Float (0.0%)
Eligible for
ISAs
SIPPs
XXII Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for XXII
Upcoming Events for XXII
Tuesday 10th December, 2019
22nd Century Group Inc at LD Micro Main Event
Similar to XXII
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.